Summary of Germany Seeks ‘Big Flip’ in Publishing Model

Looking for the article?
We have the summary! Get the key insights in just 5 minutes.

Germany Seeks ‘Big Flip’ in Publishing Model summary
Start getting smarter:
or see our plans

Rating

9 Overall

10 Importance

9 Innovation

9 Style


Recommendation

Commercial publishers charge libraries big-ticket subscription prices for access. Germany’s “Projekt DEAL” is pushing for open access based on paying publishers an annual lump sum. While Wiley and SpringerNature are close to an agreement, academic publishing giant Elsevier remains fixed in the “pay-per-use” model. Seasoned journalists Gretchen Vogel and Kai Kupferschmidt provide a clear view into Germany’s current negotiations with Elsevier to increase science accessibility. getAbstract recommends this article to those interested in open access.

In this summary, you will learn

  • What the “big flip” in academic publishing means,
  • How much one scientific article costs and
  • Why the current publishing model is teetering on extinction.
 

About the Authors

Gretchen Vogel is a journalist with over 20 years of experience. Kai Kupferschmidt studied Molecular Biomedicine and has written for Science  magazine since 2011.

 

Summary

What does the “big flip” in academic publishing mean?

Currently, libraries access journal content via subscription fees. A consortium of libraries and universities in Europe aims to replace this paradigm with an open source model. The Netherlands has successfully struck a deal with the academic publisher Elsevier to make 30% of Dutch-authored papers open source by 2018. A German consortium of libraries and universities has been working on similar negotiations for the past two years. Germany aims to replace subscription fees with...


More on this topic

By the same authors

A Modern Monster
8

Customers who read this summary also read

Is the Staggeringly Profitable Business of Scientific Publishing Bad for Science?
9
China’s AI Imperative
7
Convergence
9
The Inevitable
9
Medical Centers Spearhead China’s Pharma Push
8
Preparing for Disruption
9

Comment on this summary